Summary:
- This article provides an update on Roche's phase III clinical trial called persevERA, which is studying a new treatment for ER-positive advanced breast cancer.
- The study is investigating the use of a drug called Palbociclib in combination with endocrine therapy, which is a common treatment for this type of breast cancer.
- The results of this study could lead to a new treatment option for patients with ER-positive advanced breast cancer, potentially improving their outcomes and quality of life.